beyond glp 1 Uncovering hidden opportunities in the GLP-1 era Obesity and Beyond

Detailed application instructions are included in the application portal and should be reviewed carefully before initiating

AOD-9604 CERTIFICATES OF ANALYSIS 4 COAs BN-26AD05-001 Current Variant: Size: 5mg AOD-9604 4.94 mg / 5.25 mg Purity 99.211% / 99.329% BN-25AD05-001 Previous Variant: Size: 5mg BN-24AD05-002 Previous Variant: Size: 5mg BN-24AD05-002 Previous Variant: Size: 5mg Small-Batch Research Confidence Focused research supply, documented batch by batch

Constipation, which occurs in approximately 525% of patients depending on the specific product and dose, may cause lower back discomfort

It is important to know the difference between a manageable side effect and a serious medical concern

When restriction has already been part of the story, adding a medication that suppresses appetite is not a neutral intervention. Gastrointestinal Conditions That Require Caution Because GLP-1 medications slow gastric emptying and affect gut motility, certain GI conditions need special caution